Acarbose tablets, which affect the absorption of carbohydrate-based nutrients, can delay the degradation and absorption of glucose in the gastrointestinal tract, but does not significantly affect the absorption of other normal nutrients. Acarbose tablets is one of the hypoglycemic drugs, belongs to the alpha glucosidase inhibitors, it mainly through the delay in the intestinal degradation of polysaccharides, oligosaccharides or disaccharides, so as to make the degradation of glucose from carbohydrates and absorption of glucose into the blood slower, lowering the postprandial blood glucose, but it does not affect the absorption of other normal nutrients (such as proteins, vitamins, minerals, etc.). Common adverse reactions to acarbose tablets are mainly flatulence, but also diarrhea, bloating and, rarely, abdominal pain. Note the following conditions, Acarbose Tablets are prohibited: allergy to Acarbose Tablets; chronic gastrointestinal dysfunction with significant digestive and absorption dysfunction; gastrointestinal flatulence may lead to worsening of the disease (such as severe hiatus hernia, intestinal obstruction); severe renal insufficiency and so on. Patients should take the drug strictly under medical supervision.